Aspirin may lower cancer risk

A Harvard study suggests regular aspirin use may significantly lower cancer risk, particularly colorectal cancer. Researchers analyzed over 100,000 patients for 30 years, finding a 32% reduction in cancer incidence among regular aspirin users compared to non-users. While promising, the study emphasizes that aspirin's side effects, like bleeding, mean it's not approved for cancer prevention in Germany, and lifestyle factors remain crucial.